(Q36400926)

14 August 2017

1 reference

title

Non-motor symptoms of Parkinson's disease: diagnosis and management. (English)

1 reference

14 August 2017

1 reference

K Ray Chaudhuri

1

0 references

Anthony H V Schapira

series ordinal

3

object named as

Anthony H V Schapira

1 reference

14 August 2017

2

Daniel G Healy

1 reference

14 August 2017

National Institute for Clinical Excellence

series ordinal

4

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

3

1 reference

14 August 2017

235-245

1 reference

An Essay on the Shaking Palsy

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Factors impacting on quality of life in Parkinson's disease: results from an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Resource use and costs in a Swedish cohort of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The sleep switch: hypothalamic control of sleep and wakefulness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Idiopathic REM sleep behavior disorder: toward a better nosologic definition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The two faces of Eve: dopamine's modulation of wakefulness and sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Cognitive status correlates with neuropathologic stage in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Nocturnal symptom complex in PD and its management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Parkinson's disease and sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Parkinson's disease and sleepiness: an integral part of PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Incidental Lewy body disease in a patient with REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Excessive daytime sleepiness in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Sleep attacks and Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Range of neuropsychiatric disturbances in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Neuropsychiatric non-motor aspects of Parkinson’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Increased risk of Parkinson's disease after depression: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Are patients with Parkinson's disease suicidal?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Parkin disease: a phenotypic study of a large case series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Prospective study of phobic anxiety and risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Left-sided Parkinson's disease is associated with greater anxiety and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Pramipexole, ropinirole, and mania in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Apathy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Is fatigue an independent and persistent symptom in patients with Parkinson disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Neurobehavioural mechanisms of reward and motivation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Negative symptoms: the 'pathology' of motivation and goal-directed behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Reduced reward processing in the brains of Parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Movement disorder emergencies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Levodopa-induced psychosis: a kindling phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Disabling repetitive behaviors in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Pathological gambling is linked to reduced activation of the mesolimbic reward system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The rate of cognitive decline in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Apolipoprotein E controls the risk and age at onset of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Autonomic dysfunction in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Cardiac sympathetic denervation in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Gastrointestinal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Growth hormone response to clonidine in central and peripheral primary autonomic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Gastrointestinal dysfunction in Parkinson's disease. A report of clinical experience at a single center

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Frequency of bowel movements and the future risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Sexual function in patients with Parkinson's disease and their partners

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Dimensions of sexual dysfunction in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Oral and genital pain syndromes in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Olfactory function in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Abnormal performance on the PD test battery by asymptomatic first-degree relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Olfaction in neurodegenerative disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Assessment of sleep and sleepiness in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The Parkinson fatigue scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Desirable properties for instruments assessing quality of life: evidence from the PDQ-39.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Development and testing of the Parkinson's disease quality of life scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Systematic evaluation of rating scales for impairment and disability in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Parkinson's disease and quality of life: issues and challenges beyond motor symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Longitudinal evaluation of economic and physical impact of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Nondopaminergic mechanisms in levodopa-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970373-8

7 January 2021

10.1016/S1474-4422(06)70373-8

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16488379